Literature DB >> 15212157

Topical delivery of a model phenolic drug: alkyloxycarbonyl prodrugs of acetaminophen.

Scott C Wasdo1, Kenneth B Sloan.   

Abstract

PURPOSE: To determine whether the delivery of a phenolic parent drug by its alkyloxycarbonyl (AOC) prodrugs through hairless mouse skin would show similar dependencies on water and lipid solubilities that similar prodrugs of more polar heterocyclic amide and imide parent drugs have shown.
METHODS: Flux through hairless mouse skin from suspensions in isopropyl myristate (J(MIPM)), solubilities in IPM (S(IPM)) and water (S(AQ)), and partition coefficients between isopropyl myristate (IPM) and pH 4.0 buffer (K(IPM:4.0)) were measured for two series of AOC derivatives of acetaminophen (APAP); their solubilities in pH 4.0 buffer (S4.0) were estimated from S(IPM)/K(IPM:4.0). Log J(MIPM) values were calculated from the n = 43 coefficients for the parameters in the transformed Potts-Guy (Roberts-Sloan) equation, and the average error of prediction (delta log J'(IPM)) was calculated. The J(MIPM), S(IPM), S4.0, and molecular weight (MW) data for this series and two other series were combined with the n = 43 database to give a n = 61 database, and new best fit coefficients were determined for the Roberts-Sloan equation: log J(MIPM) = x + y log S(IPM) + (1 - y) log S4.0 - z MW.
RESULTS: All of the 4-AOC-APAP derivatives underperformed based on their predicted log J(MIPM) (delta log J'(MIPM) = 0.275 +/- 0.147 log units) and, although the two more water soluble members of this more lipid soluble series were more effective than APAP, they were only marginally so: <2 times. Addition of three new series to the n = 43 database for the Roberts-Sloan equation did not substantially change the coefficients to the parameters: x, y, z, and r2 = -0.322, 0.530, 0.00337 and 0.92, respectively.
CONCLUSIONS: The topical delivery of a model phenolic drug by its AOC prodrugs through hairless mouse skin from IPM shows the same dependence on S(IPM), S4.0, and MW as the delivery of polar heterocycles by their similar prodrugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212157     DOI: 10.1023/b:pham.0000029281.12753.25

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Application of the transformed Potts-Guy equation to in vivo human skin data.

Authors:  W J Roberts; K B Sloan
Journal:  J Pharm Sci       Date:  2001-09       Impact factor: 3.534

2.  Correlation of aqueous and lipid solubilities with flux for prodrugs of 5-fluorouracil, theophylline, and 6-mercaptopurine: A Potts-Guy approach.

Authors:  W J Roberts; K B Sloan
Journal:  J Pharm Sci       Date:  1999-05       Impact factor: 3.534

3.  Permeation of buprenorphine and its 3-alkyl-ester prodrugs through human skin.

Authors:  A L Stinchcomb; A Paliwal; R Dua; H Imoto; R W Woodard; G L Flynn
Journal:  Pharm Res       Date:  1996-10       Impact factor: 4.200

4.  Acetaminophen prodrugs. I. Synthesis, physicochemical properties, and analgesic activity.

Authors:  L W Dittert; H C Caldwell; H J Adams; G M Irwin; J V Swintosky
Journal:  J Pharm Sci       Date:  1968-05       Impact factor: 3.534

5.  Extended Hildebrand solubility approach: sulfonamides in binary and ternary solvents.

Authors:  A Martin; P L Wu; T Velasquez
Journal:  J Pharm Sci       Date:  1985-03       Impact factor: 3.534

6.  Topical delivery of 5-fluorouracil (5-Fu) by 3-alkylcarbonyl-5-Fu prodrugs.

Authors:  H D Beall; K B Sloan
Journal:  Int J Pharm       Date:  2001-04-17       Impact factor: 5.875

7.  Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin.

Authors:  Audra L Stinchcomb; Peter W Swaan; Opinya Ekabo; Kathleen K Harris; Jennifer Browe; Dana C Hammell; Todd A Cooperman; Michael Pearsall
Journal:  J Pharm Sci       Date:  2002-12       Impact factor: 3.534

8.  Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs.

Authors:  William J Roberts; Kenneth B Sloan
Journal:  J Pharm Sci       Date:  2003-05       Impact factor: 3.534

9.  Topical delivery of 5-fluorouracil and 6-mercaptopurine by their alkylcarbonyloxymethyl prodrugs from water: vehicle effects on design of prodrugs.

Authors:  Kenneth B Sloan; Scott Wasdo; Udo Ezike-Mkparu; Thomas Murray; Donna Nickels; Surjit Singh; Thea Shanks; John Tovar; Karen Ulmer; Robert Waranis
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

Review 10.  Designing for topical delivery: prodrugs can make the difference.

Authors:  Kenneth B Sloan; Scott Wasdo
Journal:  Med Res Rev       Date:  2003-11       Impact factor: 12.944

View more
  3 in total

1.  Prodrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal delivery.

Authors:  Susruta Majumdar; Maren Mueller-Spaeth; Kenneth B Sloan
Journal:  AAPS PharmSciTech       Date:  2012-05-31       Impact factor: 3.246

2.  Pharmacological screening of glycine amino acid prodrug of acetaminophen.

Authors:  Arun Parashar
Journal:  Indian J Pharmacol       Date:  2015 Mar-Apr       Impact factor: 1.200

3.  Soft alkyl ether prodrugs of a model phenolic drug: the effect of incorporation of ethyleneoxy groups on transdermal delivery.

Authors:  Joshua Denver Thomas; Susruta Majumdar; Kenneth Berry Sloan
Journal:  Molecules       Date:  2009-10-22       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.